DBRG vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

DBRG

46.9
AI Score
VS
CNS Wins

CNS

50.8
AI Score

Investment Advisor Scores

DBRG

47score
Recommendation
HOLD

CNS

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DBRG CNS Winner
Revenue 580.91M 94.41M DBRG
Net Income 247.31M 29.96M DBRG
Net Margin 42.6% 31.7% DBRG
ROE 10.5% 9.9% DBRG
ROA 6.6% 6.7% CNS
Total Assets 3.76B 450.12M DBRG
Cash 508.22M 193.73M DBRG
Free Cash Flow 47.05M 4.31M DBRG

Relative Price Performance (Last 90 Days)

DBRG 1M: +0.6% · 3M: +1.5% CNS 1M: +1.8% · 3M: +12.8%

Current Technical Phase

DBRG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 61

RSI (14): 60.7 · Price: $15.93

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.9 · Price: $81.42

Fundamentals Snapshot

Metric DBRG CNS
Market Cap
Forward P/E 19.4 20.5
Trailing P/E 10.0 25.0
Revenue (TTM)
Revenue Growth 0.6% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.5% 0.3%
EPS 1.59 3.23
Dividend Yield 0.00% 0.03%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.